Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
![Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target](https://www.mdpi.com/metabolites/metabolites-11-00690/article_deploy/html/images/metabolites-11-00690-g002-550.jpg)
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
![The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43044-021-00150-z/MediaObjects/43044_2021_150_Fig1_HTML.png)
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text
![Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association | Arteriosclerosis, Thrombosis, and Vascular Biology Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/52840b75-859f-4ac5-b558-0f605089890b/atv.0000000000000147.fig01.jpg)
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association | Arteriosclerosis, Thrombosis, and Vascular Biology
![Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention | Lipids in Health and Disease | Full Text Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention | Lipids in Health and Disease | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-019-1144-y/MediaObjects/12944_2019_1144_Fig1_HTML.png)
Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention | Lipids in Health and Disease | Full Text
![Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science | ECR Journal Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science | ECR Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/figure1-low-density-lipoprotein.png)
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science | ECR Journal
![Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE - eBioMedicine Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE - eBioMedicine](https://www.thelancet.com/cms/attachment/82a5c123-2ea3-4a0f-8123-3f1b7a7792de/gr1_lrg.jpg)
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE - eBioMedicine
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
![Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target](https://www.mdpi.com/metabolites/metabolites-11-00690/article_deploy/html/images/metabolites-11-00690-g003-550.jpg)
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
![Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-00020-3/MediaObjects/41598_2021_20_Fig1_HTML.png)
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports
![SciELO - Brasil - Índice apo B/apo A-I e predição de risco cardiovascular Índice apo B/apo A-I e predição de risco cardiovascular SciELO - Brasil - Índice apo B/apo A-I e predição de risco cardiovascular Índice apo B/apo A-I e predição de risco cardiovascular](https://minio.scielo.br/documentstore/1678-4170/CXGNHcpCGDHTZpV7YdYKNLs/491b291fddeafac50c07bdabd1599cb3d77c2612.jpg)
SciELO - Brasil - Índice apo B/apo A-I e predição de risco cardiovascular Índice apo B/apo A-I e predição de risco cardiovascular
![Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol | Journal of the American Heart Association Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/9421a1c5-e4cd-4050-b277-6480de3cc7a2/jah31791-fig-0001.gif)